Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer

BACKGROUND: The standard treatment for patients with advanced transitional cell carcinoma of the bladder is platin based chemotherapy. Only approximately 50% of the patients respond to chemotherapy. Therefore, molecular predictive markers for identification of chemotherapy sensitive subgroups of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordentoft, Iver, Dyrskjøt, Lars, Bødker, Julie S, Wild, Peter J, Hartmann, Arndt, Bertz, Simone, Lehmann, Jan, Ørntoft, Torben F, Birkenkamp-Demtroder, Karin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103475/
https://www.ncbi.nlm.nih.gov/pubmed/21489314
http://dx.doi.org/10.1186/1471-2407-11-135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103475/
https://www.ncbi.nlm.nih.gov/pubmed/21489314
http://dx.doi.org/10.1186/1471-2407-11-135

Ejemplares similares